EuroPCR 2021 | EBC MAIN: Provisional Stenting vs. Systematic Dual Stenting in Left Main Coronary Artery

Treating the left main coronary artery with provisional stenting was non-inferior to systematic dual stenting in the EBC MAIN trial, presented at EuroPCR 2021 and simultaneously published in the European Heart Journal.

stent provisional vs 2 stents sistemáticos en el tronco

The composite primary endpoint of death, infarction, and target-lesion revascularization was 14.7% for provisional stenting vs. 17.7% for systematic dual stenting (hazard ratio: 0.78; 95% confidence interval: 0.5-1.3).

This discussion of strategies for treating the left coronary artery has been going on for several years and there seems to be no end in sight.

Some studies, such as NORDIC, suggest a higher mortality with dual stenting, while others, like randomized trial DKCRUSH-V, show the opposite.

DKCRUSH-V was the study on which the 2018 European guidelines based their recommendation of the double kissing crush technique over provisional stenting to treat left main artery bifurcation.

According to the authors, the results of the EBC MAIN suggest starting in the simplest way (provisional stenting); if the results are not as expected, converting to dual stenting is still possible. About 22% of patients randomized to provisional stenting required a second stent after kissing balloon, with no predictive factor detected.

In EBC MAIN, 467 patients —from 11 European countries—with left main coronary artery bifurcation lesion were randomized to provisional stenting (n = 230) vs. systematic dual stenting (n = 237).


Read also: EuroPCR 2021 | TVT Registry: Outcomes of TAVR in Low Surgical Risk Bicuspids.


The double stenting technique was left to operator discretion (culotte, DK crush, minicrush, T/Tap), but proximal optimization and kissing end-balloon were mandatory in both strategies.

Surprisingly enough, the use of intravascular imaging was not mandatory—something that many investigators criticized after the presentation. Another questionable aspect is that there was no experience or volume requirements for centers or operators (despite the fact that their impact has been proven on clinical outcomes and other studies, such as DKCRUSH, factored them in).

EBC-MAIN

Original Title: The European Bifurcation Club Left Main coronary stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN).

Reference: Hildick-Smith D et al. Eur Heart Journal. 2021; Epub ahead of print. doi:10.1093/eurheartj/ehab283.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...